Harbin Pharmaceutical Co., Ltd. announced that the company held a board meeting on July 16, 2026 to review and pass a bill to adjust the listing and leasing method of some of the idle assets of the branch Harbin Pharmaceutical Factory 6. Previously, the company planned to list and lease this part of the assets as a whole in May 2025, but neither round of listing attracted interested leasing customers. It is currently proposed to publicly list and rent the entire building, stratification, partial or cooperative management. The target construction area of the lease is 14,656.11 square meters, and the lease period is 5 to 10 years. This transaction does not constitute a related transaction or major asset restructuring, or has a positive impact on the company's financial situation, but there is uncertainty about implementation.

Harbin Pharmaceutical Co., Ltd. announced that the company held a board meeting on July 16, 2026 to review and pass a bill to adjust the listing and leasing method of some of the idle assets of the branch Harbin Pharmaceutical Factory 6. Previously, the company planned to list and lease this part of the assets as a whole in May 2025, but neither round of listing attracted interested leasing customers. It is currently proposed to publicly list and rent the entire building, stratification, partial or cooperative management. The target construction area of the lease is 14,656.11 square meters, and the lease period is 5 to 10 years. This transaction does not constitute a related transaction or major asset restructuring, or has a positive impact on the company's financial situation, but there is uncertainty about implementation.